| Code | CSB-RA756966MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to reference antibody BT02, targeting ITPRIPL1 (Inositol 1,4,5-Trisphosphate Receptor Interacting Protein Like 1). ITPRIPL1 is a member of the inositol 1,4,5-trisphosphate receptor interacting protein family, involved in calcium signaling regulation and intracellular calcium homeostasis. This protein plays a role in modulating cellular responses to various stimuli through its interaction with IP3 receptors, which are critical for calcium release from intracellular stores. ITPRIPL1 has been implicated in neurological processes and cellular signaling pathways, making it a relevant target for investigating calcium-dependent mechanisms in health and disease.
As a biosimilar to BT02, this antibody provides researchers with a reliable tool for investigating ITPRIPL1 expression, localization, and function across various experimental systems. It supports studies exploring calcium signaling dynamics, protein-protein interactions, and the role of ITPRIPL1 in cellular physiology. This antibody is suitable for laboratories conducting basic research into calcium-mediated signaling pathways and related biological processes.
There are currently no reviews for this product.